1. Fujian Center for Disease Control and Prevention, Priority Laboratory for Zoonoses Research of Fujian, Fuzhou 350001, China; 2. School of Public Health, Fujian Medical University, Fuzhou 350108, China; 3. Fujian International Travel HealthCare Center, Fuzhou 350001, China
Abstract:To study the biological characteristics and mutations of influenza A(H1N1)pdm09 virus isolated from one case of pneumonia of unknown etiology (PUE), which would provide references for clinical treatment and disease control, the throat swab specimen from the PUE case was isolated in the Madin-Darby Canine Kidney (MDCK) cells, and then the antigenicity, pathogenicity and drug resistance of influenza A (H1N1) pdm09 virus were analyzed after sequencing. As a result, one influenza virus strain was isolated from the specimen and named as A/FujianGulou/SWL64/2016(H1N1). The similarities of nucleotide sequences and amino acids sequences compared with the vaccine strain A/California/07/2009(H1N1) were 96.9%-98.9% and 96.7%-99.5%, respectively. Eighteen amino acids had mutated in the HA and 4 mutations, K163Q, S185T, S203T and D222N, were involved in 3 different epitopes, which indicated that the antigenic drift had occurred in the influenza virus. The D222N mutation associated with receptor binding site made the virus infect lower respiratory tract more easily. The virus was still amantadine-resistance and oseltamivir-sensitive.In conclusion, the influenza A (H1N1) pdm09 virus in this study have occurred antigenic drift and has the molecular characterization of causing severe pneumonia, so further surveillance should be performed to prevent and control the influenza epidemic.
[1] WHO. Seasonal influenza reviews[EB/OL]. (2015-06-05)[2016-08-01]. http://www.who.int/influenza/surveillance_monitoring/updates/GIP_surveillance_summary_reviews_archives/en/. [2] Yang SJ, Ren H. Lemology[M]. Beijing: People’s Medical Publishing House, 2008: 62-65. (in Chinese) 杨绍基,任红.传染病学[M].北京:人民卫生出版社, 2008: 62-65. [3] WHO. Sequencing primers and protocol[EB/OL]. (2009-05-12)[2016-08-01]. http://www.who.int/csr/resources/publications/swineflu/GenomePrimers_20090512.pdf. [4] Guo YJ, Cheng XW. Influenza virus and laboratory technique[M]. Beijing: China Three Gorges Publishing House, 1997: 187-188. (in Chinese) 郭元吉, 程小雯.流行性感冒病毒及其实验技术[M].北京: 中国三峡出版社, 1997: 187-188. [5] Bright RA, Shay DK, Shu B, et al. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States[J]. Jama, 2006, 295(8): 891-894. doi:10.1001/jama.295.8.joc60020 [6] Suzuki H, Saito R, Masuda H, et al. Emergence of amantadine-resistant influenza A viruses: epidemiological study[J]. J Infect Chemother, 2003, 9(9): 195-200. doi:10.1007/s10156-003-0262-6 [7] Lejal N, Tarus B, Bouguyon E, et al. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus[J]. Antimicrob Agents Chemother, 2013, 57(5): 2231-2242. doi:10.1128/AAC.02335-12 [8] Hutchinson EC, Fodor E. Transport of the influenza virus genome from nucleus to nucleus[J]. Viruses, 2013, 5(10): 2424-2446. doi:10.3390/v5102424 [9] Resa-Infante P, Jorba N, Zamarreño N, et al. The host-dependent interaction of alpha-importins with influenza PB2 polymerase subunit is required for virus RNA replication.[J]. PLoS One, 2008, 3(12): 1632-1636. doi:10.1371/journal.pone.0003904 [10] Resa-Infante P, Gabriel G. The nuclear import machinery is a determinant of influenza virus host adaptation[J]. Bioessays, 2013, 35(1): 23-27. doi:10.1002/bies.201200138 [11] Gabriel G, Dauber B, Wolff T, et al. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host[J]. Proc Natl Acad Sci U S A, 2005, 102(51): 18590-18595. doi:10.1073/pnas.0507415102 [12] Gabriel G, Abram M, Keiner B, et al. Differential polymerase activity in avian and mammalian cells determines host range of influenza virus[J]. J Virol, 2007, 81(17): 9601-9604. doi:10.1128/JVI.00666-07 [13] Conenello GM, Tisoncik JR, Rosenzweig E, et al. A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo[J]. J Virol, 2011, 85(2): 652, 662. doi:10.1128/JVI.01987-10 [14] Nieto A, Del LS, Bárcena J, et al. Complex structure of the nuclear translocation signal of influenza virus polymerase PA subunit[J]. J General Virol, 1994, 75(Pt 1)(1): 29-36. doi:10.1099/0022-1317-75-1-29 [15] Perales B, Sanz-Ezquerro JJ, Gastaminza P, et al. The replication activity of influenza virus polymerase is linked to the capacity of the PA subunit to induce proteolysis[J]. J Virol, 2000, 74(3): 1307-1312. doi:10.1128/jvi.74.3.1307-1312.2000 [16] Fodor E, Mingay LJ, Crow M, et al. A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase promotes the generation of defective interfering RNAs[J]. J Virol, 2003, 77(8): 5017-5020. doi:10.1128/JVI.77.8.5017-5020.2003 [17] Li W, Noah JW, Noah DL. Alanine substitutions within a linker region of the influenza A virus non-structural protein 1 alter its subcellular localization and attenuate virus replication[J]. J General Virol, 2011, 92(Pt 8): 1832-1842. doi:10.1099/vir.0.031336-0 [18] Dankar SK, Miranda E, Forbes NE, et al. Influenza A/Hong Kong/156/1997(H5N1) virus NS1 gene mutations F103L and M106I both increase IFN antagonism, virulence and cytoplasmic localization but differ in binding to RIG-I and CPSF30[J]. Virol J, 2013, 10(12): 2001-2001. doi:10.1186/1743-422X-10-243 [19] Manabu I, Kimihito I, Reiko Y, et al. Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin[J]. PLoS One, 2010, 5(1): e8553. doi:10.1371/journal.pone.0008553 [20] Wiley DC, Wilson IA. Structural identification of the antibody binding sites of Hong Kong influenza hemagglutinin and their involvement in antigenic variation[J]. Nature, 1981, 289: 373-378. doi:10.1038/289373a0 [21] Yan LP, Zhou YJ, Li GX, et al. Molecular and genetic characteristics of hemagglutinin and neuraminidase genes of China 2009 pandemic swine-origin influenza A(H1N1) virus[J]. Chin J Anim Infect Dis, 2010, 18(4): 13-19. doi:10.3969/j.issn.1674-6422.2010.04.003 (in Chinese) 闫丽萍, 周艳君, 李国新, 等.中国流行的2009年甲型H1N1猪源流感病毒HA和 NA基因的分子和遗传特征[J]. 中国动物传染病学报, 2010, 18(4): 13-19. [22] Gambaryan AS, Tuzikov AB, Piskarev VE, et al. Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6'-sialyl (N-acetyllactosamine)[J]. Virology, 1997, 232(2): 345-350. doi:10.1006/viro.1997.8572 [23] Kong W, Liu L, Wang Y, et al. Hemagglutinin mutation D222N of the 2009 pandemic H1N1 influenza virus alters receptor specificity without affecting virulence in mice[J]. Virus Res, 2014, 189: 79-86. doi:10.1016/j.virusres.2014.05.001 [24] Houng HSH, Garner J, Zhou Y, et al. Emergent 2009 influenza A(H1N1) viruses containing HA D222N mutation associated with severe clinical outcomes in the Americas[J]. J Clin Virol, 2012, 53(1): 12-15. doi:10.1016/j.jcv.2011.09.004